Pentoxifylline Tablet, Extended Release
Product Images NDC 71335-2586

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pentoxifylline (NDC 71335-2586). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352586)

Pentoxifylline Extended-Release Tablets, USP 400 mg oral tablets repackaged by Bryant Ranch Prepack. The label indicates a package size of 30 tablets and includes storage instructions to keep between 20° to 25°C in a light-resistant container. Manufacturer listed as Unique Pharmaceutical Laboratories.*

FDA Label Image

Pentoxifyllinestruct (Pentoxifyllinestruct)

Chemical structure of pentoxifylline, showing its molecular framework including methyl groups, carbonyl groups, and nitrogen atoms in the heterocyclic rings.*

FDA Label Image

Pentoxifyllinetable (Pentoxifyllinetable)

A data table comparing adverse event rates between Pentoxifylline extended-release tablets and placebo, as well as immediate-release capsules used in controlled clinical trials. The table categorizes side effects by cardiovascular, digestive, and nervous system symptoms with corresponding percentages and numbers of patients at risk for each formulation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.